Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Avantel Ltd
| Quarterly Financial Results Q3 FY 2025-26
Summary : Avantel Limited reported significantly lower Q3 and 9M FY26 profits and revenues, with a key government customer and a subsidiary's unreviewed financials.
Quarterly Report Analysis & Insights
Financial Disclosures
- Standalone Total Expenses Q3 FY26: 4392.31 Lakhs (vs 4162.29 Lakhs in Q3 FY25).
- Standalone Total Expenses 9M FY26: 13702.40 Lakhs (vs 12747.89 Lakhs in 9M FY25).
- Consolidated Total Expenses Q3 FY26: 4630.77 Lakhs (vs 4270.95 Lakhs in Q3 FY25).
- Consolidated Total Expenses 9M FY26: 14308.01 Lakhs (vs 13022.14 Lakhs in 9M FY25).
- Employee benefits expense includes ESOP costs of Rs. 177.19 Lakhs for Q3 FY26.
- No provision for loss allowance made on receivables.
- Receivables assured due to Government of India customer.
- Standalone Revenue from operations Q3 FY26: 5124.52 Lakhs (vs 7043.83 Lakhs in Q3 FY25).
- Standalone Total Revenue from operations 9M FY26: 15820.57 Lakhs (vs 19934.10 Lakhs in 9M FY25).
- Consolidated Revenue from operations Q3 FY26: 5171.58 Lakhs (vs 7068.08 Lakhs in Q3 FY25).
- Consolidated Total Revenue from operations 9M FY26: 15904.69 Lakhs (vs 19986.49 Lakhs in 9M FY25).
- Segment Revenue - Communications and signal processing products: 15957.36 Lakhs (9M FY26).
- Segment Revenue - Health Care: 84.13 Lakhs (9M FY26).
- Consolidated Total Assets as of Dec 31, 2025: 41,463.76 Lakhs.
- Consolidated Total Liabilities as of Dec 31, 2025: 8,410.70 Lakhs.
- Both standalone and consolidated unaudited financial results are presented.
- Separate limited review reports issued for standalone and consolidated results.
Corporate Overview
- Primarily India, with the Government of India as a principal customer.
- Significant dependency on a single principal customer controlled by the Government of India.
- Manufacturing of Wireless Front End, Satellite communication, Embedded Systems, Signal Processing, Network Management, Software development, and customer support services.
- In-house R&D Facility for communications and signal processing products.
- Manufacturing of Disposable Skin Staplers, Removers, and Oxygen Concentrators for health care services.
- Factual and formal reporting of financial results and auditor reviews.
- Principal customer is an organization controlled by the Government of India.
- Communications and signal processing products
- Health Care Services
Risk Factors
- High dependency on government customer.
- Need to reassess loss allowance model.
- Subsidiary results not auditor reviewed.
- Significant decline in profit before tax.
Key Drivers
- Allotted equity shares to employees.
- Focus on core competence growth.
- Government of India as key customer.
- In-house R&D facility.
Auditor’s Report
- Review conclusion: Nothing came to attention causing belief of material misstatement.
- No audit opinion expressed as it was a limited review.
Corporate Governance
- Audit Committee reviewed the financial results.
Management Discussion & Analysis
Future Strategy
- Corporate strategy aims at creating multiple drivers of growth.
- Growth anchored on the company's core competence.
- Currently focused on two segments: Communications and Health Care.